{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:21:33Z","timestamp":1793316093527,"version":"4.5.0"},"reference-count":188,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing medical scientific research project","award":["2024ZDXM008"],"award-info":[{"award-number":["2024ZDXM008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203823"],"award-info":[{"award-number":["82203823"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"the Natural Science Foundation of Chongqing","doi-asserted-by":"crossref","award":["CSTB2024NSCQ-QCXMX0051"],"award-info":[{"award-number":["CSTB2024NSCQ-QCXMX0051"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02678-7","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:03:11Z","timestamp":1778306591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Organoids in cancer therapy: translational applications and clinical promise"],"prefix":"10.1186","volume":"25","author":[{"given":"Mingzhen","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"11","key":"2678_CR1","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","volume":"66","author":"Y Wang","year":"2023","unstructured":"Wang Y, Yan Q, Fan C, Mo Y, Wang Y, Li X, Liao Q, Guo C, Li G, Zeng Z, et al. Overview and countermeasures of cancer burden in China. Sci China Life Sci. 2023;66(11):2515\u201326.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2678_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"2678_CR3","doi-asserted-by":"crossref","unstructured":"Zhang G, Liang Q, Wu Y, Wang Y. Insights on the differences between two\u2013 and three\u2013dimensional culture systems in tumor models (Review). Int J Mol Med. 2025;56(5):185.","DOI":"10.3892\/ijmm.2025.5626"},{"issue":"6194","key":"2678_CR4","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345(6194):1247125.","journal-title":"Science"},{"issue":"4","key":"2678_CR5","first-page":"266","volume":"32","author":"K Duval","year":"2017","unstructured":"Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, Chen Z. Modeling Physiological Events in 2D vs. 3D Cell Culture. Physiol (Bethesda). 2017;32(4):266\u201377.","journal-title":"Physiol (Bethesda)"},{"issue":"1","key":"2678_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","volume":"13","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Applications of patient-derived tumor xenograft models and tumor organoids. J Hematol Oncol. 2020;13(1):4.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2678_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc.2016.140","volume":"17","author":"AT Byrne","year":"2017","unstructured":"Byrne AT, Alferez DG, Amant F, Annibali D, Arribas J, Biankin AV, Bruna A, Budinska E, Caldas C, Chang DK, et al. Interrogating open issues in cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17(4):254\u201368.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2678_CR8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.7150\/thno.91362","volume":"14","author":"J Lv","year":"2024","unstructured":"Lv J, Du X, Wang M, Su J, Wei Y, Xu C. Construction of tumor organoids and their application to cancer research and therapy. Theranostics. 2024;14(3):1101\u201325.","journal-title":"Theranostics"},{"issue":"14","key":"2678_CR9","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.7150\/ijbs.118304","volume":"21","author":"L Li","year":"2025","unstructured":"Li L, Liu Y, Liu L, Zhao S, Feng J, Zhou J, Zhang Y, Shen X, Wang X, Chen K, et al. Human Pluripotent Stem Cell-Derived Alveolar Organoids for Gene-editing and Lung Adenocarcinomas Modeling. Int J Biol Sci. 2025;21(14):6285\u2013304.","journal-title":"Int J Biol Sci"},{"issue":"7244","key":"2678_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature07935","volume":"459","author":"T Sato","year":"2009","unstructured":"Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459(7244):262\u20135.","journal-title":"Nature"},{"issue":"1","key":"2678_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1073\/pnas.84.1.136","volume":"84","author":"ML Li","year":"1987","unstructured":"Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci U S A. 1987;84(1):136\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2678_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1530\/jrf.0.0620625","volume":"62","author":"M Evans","year":"1981","unstructured":"Evans M. Origin of mouse embryonal carcinoma cells and the possibility of their direct isolation into tissue culture. J Reprod Fertil. 1981;62(2):625\u201331.","journal-title":"J Reprod Fertil"},{"issue":"649","key":"2678_CR13","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1126\/science.25.649.912","volume":"25","author":"HV Wilson","year":"1907","unstructured":"Wilson HV. A New Method by Which Sponges May Be Artificially Reared. Science. 1907;25(649):912\u20135.","journal-title":"Science"},{"issue":"5","key":"2678_CR14","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology. 2011;141(5):1762\u201372.","journal-title":"Gastroenterology"},{"issue":"1","key":"2678_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, Dowling C, Wanjala JN, Undvall EA, Arora VK, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176\u201387.","journal-title":"Cell"},{"issue":"1\u20132","key":"2678_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS, et al. Organoid models of human and mouse ductal pancreatic cancer. Cell. 2015;160(1\u20132):324\u201338.","journal-title":"Cell"},{"issue":"8","key":"2678_CR17","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","volume":"76","author":"CG Hubert","year":"2016","unstructured":"Hubert CG, Rivera M, Spangler LC, Wu Q, Mack SC, Prager BC, Couce M, McLendon RE, Sloan AE, Rich JN. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo. Cancer Res. 2016;76(8):2465\u201377.","journal-title":"Cancer Res"},{"issue":"11","key":"2678_CR18","doi-asserted-by":"publisher","first-page":"955","DOI":"10.15252\/msb.20177697","volume":"13","author":"J Jabs","year":"2017","unstructured":"Jabs J, Zickgraf FM, Park J, Wagner S, Jiang X, Jechow K, Kleinheinz K, Toprak UH, Schneider MA, Meister M, et al. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Mol Syst Biol. 2017;13(11):955.","journal-title":"Mol Syst Biol"},{"issue":"12","key":"2678_CR19","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarro LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"5","key":"2678_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","volume":"7","author":"C Pauli","year":"2017","unstructured":"Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, et al. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7(5):462\u201377.","journal-title":"Cancer Discov"},{"issue":"2","key":"2678_CR21","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, et al. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell. 2018;173(2):515\u201328. e517.","journal-title":"Cell"},{"issue":"1\u20132","key":"2678_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H, et al. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell. 2018;172(1\u20132):373\u201386. e310.","journal-title":"Cell"},{"issue":"11","key":"2678_CR23","first-page":"1315","volume":"21","author":"S Fan","year":"2018","unstructured":"Fan S, Yin J, Wang M, Guan W. [Establishment and application of gastric and gastric cancer organoids]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(11):1315\u201320.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"1","key":"2678_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","volume":"15","author":"CM Cattaneo","year":"2020","unstructured":"Cattaneo CM, Dijkstra KK, Fanchi LF, Kelderman S, Kaing S, van Rooij N, van den Brink S, Schumacher TN, Voest EE. Tumor organoid-T-cell coculture systems. Nat Protoc. 2020;15(1):15\u201339.","journal-title":"Nat Protoc"},{"issue":"9","key":"2678_CR25","doi-asserted-by":"publisher","first-page":"100161","DOI":"10.1016\/j.xcrm.2020.100161","volume":"1","author":"S Jiang","year":"2020","unstructured":"Jiang S, Zhao H, Zhang W, Wang J, Liu Y, Cao Y, Zheng H, Hu Z, Wang S, Zhu Y, et al. An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity. Cell Rep Med. 2020;1(9):100161.","journal-title":"Cell Rep Med"},{"issue":"4","key":"2678_CR26","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.stem.2025.01.002","volume":"32","author":"T Peng","year":"2025","unstructured":"Peng T, Ma X, Hua W, Wang C, Chu Y, Sun M, Fermi V, Hamelmann S, Lindner K, Shao C, et al. Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy. Cell Stem Cell. 2025;32(4):652\u2013e669611.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2678_CR27","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.stem.2020.04.003","volume":"26","author":"BE Michels","year":"2020","unstructured":"Michels BE, Mosa MH, Streibl BI, Zhan T, Menche C, Abou-El-Ardat K, Darvishi T, Czlonka E, Wagner S, Winter J, et al. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids. Cell Stem Cell. 2020;26(5):782\u201392. e787.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2678_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12943-025-02479-4","volume":"24","author":"F Dabbagh Moghaddam","year":"2025","unstructured":"Dabbagh Moghaddam F, Anvar A, Ilkhani E, Dadgar D, Rafiee M, Ranjbaran N, Mortazavi P, Ghoreishian SM, Huh YS, Makvandi P. Advances in engineering immune-tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery. Mol Cancer. 2025;24(1):271.","journal-title":"Mol Cancer"},{"key":"2678_CR29","doi-asserted-by":"publisher","first-page":"107742","DOI":"10.1016\/j.oraloncology.2025.107742","volume":"171","author":"R Doerfler","year":"2025","unstructured":"Doerfler R, Chen J, Kim C, Smith JD, Harris M, Singh KB, Isett B, Dadey RE, Brown DD, Lee AV, et al. Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer. Oral Oncol. 2025;171:107742.","journal-title":"Oral Oncol"},{"key":"2678_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","volume":"97","author":"AD Theocharis","year":"2016","unstructured":"Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4\u201327.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"2678_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41578-020-0199-8","volume":"5","author":"EA Aisenbrey","year":"2020","unstructured":"Aisenbrey EA, Murphy WL. Synthetic alternatives to Matrigel. Nat Rev Mater. 2020;5(7):539\u201351.","journal-title":"Nat Rev Mater"},{"key":"2678_CR32","doi-asserted-by":"crossref","unstructured":"de Lau WBM, Wijnakker J, van Son GJF, Krueger D, Wang D, Abendroth MS, Schreurs R, Janda CY, van Rijt FLH, Chalopin BJP et al. A single-chain derivative of an integrin-activating antibody potentiates organoid growth in Matrigel and collagen hydrogels. Nat Biotechnol. 2025:1\u201311.","DOI":"10.1038\/s41587-025-02874-8"},{"key":"2678_CR33","doi-asserted-by":"publisher","first-page":"122141","DOI":"10.1016\/j.biomaterials.2023.122141","volume":"299","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Deng T, Tao M, Lin L, Sun L, Song X, Gao D, Li J, Wang Z, Wang X, et al. Snail-inspired AFG\/GelMA hydrogel accelerates diabetic wound healing via inflammatory cytokines suppression and macrophage polarization. Biomaterials. 2023;299:122141.","journal-title":"Biomaterials"},{"issue":"11","key":"2678_CR34","doi-asserted-by":"publisher","first-page":"114874","DOI":"10.1016\/j.celrep.2024.114874","volume":"43","author":"A Kjar","year":"2024","unstructured":"Kjar A, Haschert MR, Zepeda JC, Simmons AJ, Yates A, Chavarria D, Fernandez M, Robertson G, Abdulrahman AM, Kim H, et al. Biofunctionalized gelatin hydrogels support development and maturation of iPSC-derived cortical organoids. Cell Rep. 2024;43(11):114874.","journal-title":"Cell Rep"},{"key":"2678_CR35","doi-asserted-by":"crossref","unstructured":"Barros NR, Kim HJ, Gouidie MJ, Lee K, Bandaru P, Banton EA, Sarikhani E, Sun W, Zhang S, Cho HJ et al. Biofabrication of endothelial cell, dermal fibroblast, and multilayered keratinocyte layers for skin tissue engineering. Biofabrication. 2021;13(3):035030.","DOI":"10.1088\/1758-5090\/aba503"},{"issue":"10","key":"2678_CR36","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41570-022-00420-7","volume":"6","author":"J Lou","year":"2022","unstructured":"Lou J, Mooney DJ. Chemical strategies to engineer hydrogels for cell culture. Nat Rev Chem. 2022;6(10):726\u201344.","journal-title":"Nat Rev Chem"},{"key":"2678_CR37","doi-asserted-by":"crossref","unstructured":"Sanz-Fraile H, Herranz-Diez C, Ulldemolins A, Falcones B, Almendros I, Gavara N, Sunyer R, Farre R, Otero J. Characterization of Bioinks Prepared via Gelifying Extracellular Matrix from Decellularized Porcine Myocardia. Gels. 2023;9(9):745.","DOI":"10.3390\/gels9090745"},{"issue":"34","key":"2678_CR38","doi-asserted-by":"publisher","first-page":"e2400306","DOI":"10.1002\/adma.202400306","volume":"36","author":"E Garreta","year":"2024","unstructured":"Garreta E, Moya-Rull D, Marco A, Amato G, Ullate-Agote A, Tarantino C, Gallo M, Esporrin-Ubieto D, Centeno A, Vilas-Zornoza A, et al. Natural Hydrogels Support Kidney Organoid Generation and Promote In Vitro Angiogenesis. Adv Mater. 2024;36(34):e2400306.","journal-title":"Adv Mater"},{"issue":"20","key":"2678_CR39","doi-asserted-by":"publisher","first-page":"eadl3511","DOI":"10.1126\/sciadv.adl3511","volume":"10","author":"H Song","year":"2024","unstructured":"Song H, Jiang H, Hu W, Hai Y, Cai Y, Li H, Liao Y, Huang Y, Lv X, Zhang Y, et al. Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids. Sci Adv. 2024;10(20):eadl3511.","journal-title":"Sci Adv"},{"issue":"7630","key":"2678_CR40","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nature20168","volume":"539","author":"N Gjorevski","year":"2016","unstructured":"Gjorevski N, Sachs N, Manfrin A, Giger S, Bragina ME, Ordonez-Moran P, Clevers H, Lutolf MP. Designer matrices for intestinal stem cell and organoid culture. Nature. 2016;539(7630):560\u20134.","journal-title":"Nature"},{"issue":"11","key":"2678_CR41","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1038\/ncb3632","volume":"19","author":"R Cruz-Acuna","year":"2017","unstructured":"Cruz-Acuna R, Quiros M, Farkas AE, Dedhia PH, Huang S, Siuda D, Garcia-Hernandez V, Miller AJ, Spence JR, Nusrat A, et al. Synthetic hydrogels for human intestinal organoid generation and colonic wound repair. Nat Cell Biol. 2017;19(11):1326\u201335.","journal-title":"Nat Cell Biol"},{"key":"2678_CR42","doi-asserted-by":"crossref","unstructured":"Bock N, Forouz F, Hipwood L, Clegg J, Jeffery P, Gough M, van Wyngaard T, Pyke C, Adams MN, Bray LJ et al. GelMA, Click-Chemistry Gelatin and Bioprinted Polyethylene Glycol-Based Hydrogels as 3D Ex Vivo Drug Testing Platforms for Patient-Derived Breast Cancer Organoids. Pharmaceutics. 2023;15(1):261.","DOI":"10.3390\/pharmaceutics15010261"},{"key":"2678_CR43","doi-asserted-by":"publisher","first-page":"101818","DOI":"10.1016\/j.mtbio.2025.101818","volume":"32","author":"XY Chen","year":"2025","unstructured":"Chen XY, Wang MY, Shu X, Li J, Tang R, Liu XQ. Matrix-bound EGF promotes malignant phenotypes of breast cancer organoids in the biomimetic ECM of alginate. Mater Today Bio. 2025;32:101818.","journal-title":"Mater Today Bio"},{"issue":"5","key":"2678_CR44","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1021\/acsbiomaterials.4c01632","volume":"11","author":"I Kopyeva","year":"2025","unstructured":"Kopyeva I, Bretherton RC, Ayers JL, Yu M, Grady WM, DeForest CA. Matrix Stiffness and Biochemistry Govern Colorectal Cancer Cell Growth and Signaling in User-Programmable Synthetic Hydrogels. ACS Biomater Sci Eng. 2025;11(5):2810\u201323.","journal-title":"ACS Biomater Sci Eng"},{"issue":"8","key":"2678_CR45","doi-asserted-by":"publisher","first-page":"e2300502","DOI":"10.1002\/adbi.202300502","volume":"8","author":"VM Quiroz","year":"2024","unstructured":"Quiroz VM, Wang Y, Rakoski AI, Kasinathan D, Neshat SY, Hollister-Lock J, Doloff JC. Hydrogel Alginate Considerations for Improved 3D Matrix Stability and Cell Graft Viability and Function in Studying Type 1 Diabetes In Vitro. Adv Biol (Weinh). 2024;8(8):e2300502.","journal-title":"Adv Biol (Weinh)"},{"issue":"17","key":"2678_CR46","doi-asserted-by":"publisher","first-page":"e2203148","DOI":"10.1002\/adhm.202203148","volume":"12","author":"S Asim","year":"2023","unstructured":"Asim S, Tabish TA, Liaqat U, Ozbolat IT, Rizwan M. Advances in Gelatin Bioinks to Optimize Bioprinted Cell Functions. Adv Healthc Mater. 2023;12(17):e2203148.","journal-title":"Adv Healthc Mater"},{"issue":"5986","key":"2678_CR47","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","volume":"328","author":"D Huh","year":"2010","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662\u20138.","journal-title":"Science"},{"issue":"6","key":"2678_CR48","doi-asserted-by":"publisher","first-page":"e2307051","DOI":"10.1002\/adma.202307051","volume":"36","author":"C Lou","year":"2024","unstructured":"Lou C, Yang H, Hou Y, Huang H, Qiu J, Wang C, Sang Y, Liu H, Han L. Microfluidic Platforms for Real-Time In Situ Monitoring of Biomarkers for Cellular Processes. Adv Mater. 2024;36(6):e2307051.","journal-title":"Adv Mater"},{"key":"2678_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcdb.2022.10.001","volume":"144","author":"G Saorin","year":"2023","unstructured":"Saorin G, Caligiuri I, Rizzolio F. Microfluidic organoids-on-a-chip: The future of human models. Semin Cell Dev Biol. 2023;144:41\u201354.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"2678_CR50","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41467-025-56275-1","volume":"16","author":"A Perucca","year":"2025","unstructured":"Perucca A, Llonin AG, Benach OM, Hallopeau C, Rivas EI, Linares J, Garrido M, Sallent-Aragay A, Golde T, Colombelli J, et al. Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing. Nat Commun. 2025;16(1):1279.","journal-title":"Nat Commun"},{"key":"2678_CR51","doi-asserted-by":"publisher","first-page":"761807","DOI":"10.3389\/fcell.2021.761807","volume":"9","author":"M Geyer","year":"2021","unstructured":"Geyer M, Queiroz K. Microfluidic Platforms for High-Throughput Pancreatic Ductal Adenocarcinoma Organoid Culture and Drug Screening. Front Cell Dev Biol. 2021;9:761807.","journal-title":"Front Cell Dev Biol"},{"issue":"27","key":"2678_CR52","doi-asserted-by":"publisher","first-page":"e2302640","DOI":"10.1002\/advs.202302640","volume":"10","author":"Z Zou","year":"2023","unstructured":"Zou Z, Lin Z, Wu C, Tan J, Zhang J, Peng Y, Zhang K, Li J, Wu M, Zhang Y. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients. Adv Sci (Weinh). 2023;10(27):e2302640.","journal-title":"Adv Sci (Weinh)"},{"key":"2678_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41378-022-00370-6","volume":"8","author":"MR Haque","year":"2022","unstructured":"Haque MR, Wessel CR, Leary DD, Wang C, Bhushan A, Bishehsari F. Patient-derived pancreatic cancer-on-a-chip recapitulates the tumor microenvironment. Microsyst Nanoeng. 2022;8:36.","journal-title":"Microsyst Nanoeng"},{"issue":"6","key":"2678_CR54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","volume":"29","author":"S Ding","year":"2022","unstructured":"Ding S, Hsu C, Wang Z, Natesh NR, Millen R, Negrete M, Giroux N, Rivera GO, Dohlman A, Bose S, et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell. 2022;29(6):905\u201317. e906.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2678_CR55","doi-asserted-by":"publisher","first-page":"e2303088","DOI":"10.1002\/advs.202303088","volume":"11","author":"D Choi","year":"2024","unstructured":"Choi D, Gonzalez-Suarez AM, Dumbrava MG, Medlyn M, de Hoyos-Vega JM, Cichocki F, Miller JS, Ding L, Zhu M, Stybayeva G, et al. Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy. Adv Sci (Weinh). 2024;11(5):e2303088.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2678_CR56","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.1038\/s41467-020-19058-4","volume":"11","author":"B Schuster","year":"2020","unstructured":"Schuster B, Junkin M, Kashaf SS, Romero-Calvo I, Kirby K, Matthews J, Weber CR, Rzhetsky A, White KP, Tay S. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Nat Commun. 2020;11(1):5271.","journal-title":"Nat Commun"},{"issue":"1","key":"2678_CR57","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41378-025-01068-1","volume":"11","author":"D Lin","year":"2025","unstructured":"Lin D, Luo Y, Chen J, Ma Z, Kang H, Wang X, Wang L, Liu D. Single-Cell-Derived Tumor Organoid (STO) arrays on a microfluidic chip for personalized drug screening to address heterogeneity-induced drug resistance in colorectal cancer. Microsyst Nanoeng. 2025;11(1):253.","journal-title":"Microsyst Nanoeng"},{"issue":"1","key":"2678_CR58","doi-asserted-by":"publisher","first-page":"20173","DOI":"10.1038\/s41598-022-20096-9","volume":"12","author":"ST Seiler","year":"2022","unstructured":"Seiler ST, Mantalas GL, Selberg J, Cordero S, Torres-Montoya S, Baudin PV, Ly VT, Amend F, Tran L, Hoffman RN, et al. Modular automated microfluidic cell culture platform reduces glycolytic stress in cerebral cortex organoids. Sci Rep. 2022;12(1):20173.","journal-title":"Sci Rep"},{"key":"2678_CR59","doi-asserted-by":"crossref","unstructured":"Ruan J, Gao C, Wang R, Hu B, Long R, Hacimuftuoglu A, Liao B, Chen L, Ma D, Xi L et al. A novel dual-effect bimodal chip cancer research platform: Chips system interconnected vascularized tumor organoids culture with real-time exploration and detection from bench to bedside. Cancer Lett. 2025;640:218110.","DOI":"10.1016\/j.canlet.2025.218110"},{"issue":"9","key":"2678_CR60","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.drudis.2016.07.003","volume":"21","author":"A Skardal","year":"2016","unstructured":"Skardal A, Shupe T, Atala A. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. Drug Discov Today. 2016;21(9):1399\u2013411.","journal-title":"Drug Discov Today"},{"issue":"1","key":"2678_CR61","doi-asserted-by":"publisher","first-page":"8837","DOI":"10.1038\/s41598-017-08879-x","volume":"7","author":"A Skardal","year":"2017","unstructured":"Skardal A, Murphy SV, Devarasetty M, Mead I, Kang HW, Seol YJ, Shrike Zhang Y, Shin SR, Zhao L, Aleman J, et al. Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci Rep. 2017;7(1):8837.","journal-title":"Sci Rep"},{"issue":"6","key":"2678_CR62","doi-asserted-by":"publisher","first-page":"e2412815","DOI":"10.1002\/adma.202412815","volume":"37","author":"Y Du","year":"2025","unstructured":"Du Y, Wang YR, Bao QY, Xu XX, Xu C, Wang S, Liu Q, Liu F, Zeng YL, Wang YJ, et al. Personalized Vascularized Tumor Organoid-on-a-Chip for Tumor Metastasis and Therapeutic Targeting Assessment. Adv Mater. 2025;37(6):e2412815.","journal-title":"Adv Mater"},{"key":"2678_CR63","doi-asserted-by":"crossref","unstructured":"Jin J, Chen W, Li J, Yang J, Dai R, Tang J, Li M, Chen Y, Zhang C, Liu J. Engineered tumor microspheres via microfluidics and decellularized extracellular matrix for high-throughput organoid-based drug screening. Biofabrication. 2025;17(4):045003.","DOI":"10.1088\/1758-5090\/adf099"},{"issue":"5","key":"2678_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41578-018-0006-y","volume":"3","author":"L Moroni","year":"2018","unstructured":"Moroni L, Burdick JA, Highley C, Lee SJ, Morimoto Y, Takeuchi S, Yoo JJ. Biofabrication strategies for 3D in vitro models and regenerative medicine. Nat Rev Mater. 2018;3(5):21\u201337.","journal-title":"Nat Rev Mater"},{"key":"2678_CR65","doi-asserted-by":"crossref","unstructured":"Mao S, Xie R, Shou J, Pang Y, Sun W. Bioprinting of patient-derived heterogeneous renal cell carcinoma organoids for personalized therapy. Biofabrication. 2025;17(4):045008.","DOI":"10.1088\/1758-5090\/adecc5"},{"issue":"26","key":"2678_CR66","doi-asserted-by":"publisher","first-page":"e2300905","DOI":"10.1002\/adhm.202300905","volume":"12","author":"W Shi","year":"2023","unstructured":"Shi W, Mirza S, Kuss M, Liu B, Hartin A, Wan S, Kong Y, Mohapatra B, Krishnan M, Band H, et al. Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low-Concentration Collagen-Based Bioinks. Adv Healthc Mater. 2023;12(26):e2300905.","journal-title":"Adv Healthc Mater"},{"key":"2678_CR67","doi-asserted-by":"crossref","unstructured":"Dai R, Chen W, Chen Y, Jin J, Zhang S, Zhang C, Liu J. 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation. Biofabrication. 2024;16(3):035026.","DOI":"10.1088\/1758-5090\/ad51a6"},{"issue":"12","key":"2678_CR68","doi-asserted-by":"publisher","first-page":"e2400223","DOI":"10.1002\/smtd.202400223","volume":"8","author":"X Xu","year":"2024","unstructured":"Xu X, Li H, Chen J, Lv C, He W, Zhang X, Feng Q, Dong H. A Universal Strategy to Construct High-Performance Homo- and Heterogeneous Microgel Assembly Bioinks. Small Methods. 2024;8(12):e2400223.","journal-title":"Small Methods"},{"issue":"1","key":"2678_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41405-024-00219-2","volume":"10","author":"J Klangprapan","year":"2024","unstructured":"Klangprapan J, Souza GR, Ferreira JN. Bioprinting salivary gland models and their regenerative applications. BDJ Open. 2024;10(1):39.","journal-title":"BDJ Open"},{"issue":"9","key":"2678_CR70","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1111\/febs.70002","volume":"292","author":"JS Bjerring","year":"2025","unstructured":"Bjerring JS, Khodour Y, Peterson EA, Sachs PC, Bruno RD. Intercellular mitochondrial transfer contributes to microenvironmental redirection of cancer cell fate. FEBS J. 2025;292(9):2306\u201322.","journal-title":"FEBS J"},{"key":"2678_CR71","doi-asserted-by":"crossref","unstructured":"Choi YM, Lee H, Ann M, Song M, Rheey J, Jang J. 3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation. Biofabrication. 2023;15(3):034104.","DOI":"10.1088\/1758-5090\/acd95f"},{"issue":"3","key":"2678_CR72","doi-asserted-by":"publisher","first-page":"694","DOI":"10.18063\/ijb.694","volume":"9","author":"P Wang","year":"2023","unstructured":"Wang P, Sun L, Li C, Jin B, Yang H, Wu B, Mao Y. Study on drug screening multicellular model for colorectal cancer constructed by three-dimensional bioprinting technology. Int J Bioprint. 2023;9(3):694.","journal-title":"Int J Bioprint"},{"key":"2678_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2025.05.023","volume":"199","author":"Y Li","year":"2025","unstructured":"Li Y, Huang D, Zhang Y, Xiao Y, Zhang X. Microfluidic-assisted engineering of hydrogels with microscale complexity. Acta Biomater. 2025;199:1\u201317.","journal-title":"Acta Biomater"},{"key":"2678_CR74","doi-asserted-by":"publisher","first-page":"1384450","DOI":"10.3389\/fcell.2024.1384450","volume":"12","author":"S Yan","year":"2024","unstructured":"Yan S, He Y, Zhu Y, Ye W, Chen Y, Zhu C, Zhan F, Ma Z. Human patient derived organoids: an emerging precision medicine model for gastrointestinal cancer research. Front Cell Dev Biol. 2024;12:1384450.","journal-title":"Front Cell Dev Biol"},{"key":"2678_CR75","doi-asserted-by":"publisher","first-page":"103337","DOI":"10.1016\/j.cis.2024.103337","volume":"335","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, He J, Zhu D, Chen Y, Fu M, Lu S, Qiu Y, Zhou G, Yang G, Jiang Z. Genetically modified organoids for tissue engineering and regenerative medicine. Adv Colloid Interface Sci. 2025;335:103337.","journal-title":"Adv Colloid Interface Sci"},{"key":"2678_CR76","doi-asserted-by":"crossref","unstructured":"He J, Papa G, Azizi F, Kirsche L, Artola-Boran M, Ferreira Cassio R, Hotz AL, Geiger G, Francas B, Weber A et al. Gastric Organoid-Based Ectopic and Orthotopic In Vivo CRISPR Screening for Tumor Suppressors in Gastric Cancer. Gastroenterology. 2025;170(3):495\u2013510.","DOI":"10.1053\/j.gastro.2025.09.009"},{"issue":"10","key":"2678_CR77","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/iub.2855","volume":"76","author":"S Liu","year":"2024","unstructured":"Liu S, Zhang Z, Wang Z, Li J, Shen L. Genome-wide CRISPR screening identifies the pivotal role of ANKRD42 in colorectal cancer metastasis through EMT regulation. IUBMB Life. 2024;76(10):803\u201319.","journal-title":"IUBMB Life"},{"issue":"6","key":"2678_CR78","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1158\/2159-8290.CD-20-1109","volume":"11","author":"YH Lo","year":"2021","unstructured":"Lo YH, Kolahi KS, Du Y, Chang CY, Krokhotin A, Nair A, Sobba WD, Karlsson K, Jones SJ, Longacre TA, et al. A CRISPR\/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation. Cancer Discov. 2021;11(6):1562\u201381.","journal-title":"Cancer Discov"},{"issue":"5","key":"2678_CR79","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","volume":"183","author":"K Kawasaki","year":"2020","unstructured":"Kawasaki K, Toshimitsu K, Matano M, Fujita M, Fujii M, Togasaki K, Ebisudani T, Shimokawa M, Takano A, Takahashi S, et al. An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping. Cell. 2020;183(5):1420\u2013e14351421.","journal-title":"Cell"},{"issue":"6","key":"2678_CR80","doi-asserted-by":"publisher","first-page":"101490","DOI":"10.1016\/j.jcmgh.2025.101490","volume":"19","author":"AA Guenther","year":"2025","unstructured":"Guenther AA, Ahn S, Min J, Zhang C, Lee HJ, Yang HK, Sung BH, Weaver AM, Choi E. Cortactin Facilitates Malignant Transformation of Dysplastic Cells in Gastric Cancer Development. Cell Mol Gastroenterol Hepatol. 2025;19(6):101490.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"8","key":"2678_CR81","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-018-0070-7","volume":"15","author":"S Bian","year":"2018","unstructured":"Bian S, Repic M, Guo Z, Kavirayani A, Burkard T, Bagley JA, Krauditsch C, Knoblich JA. Genetically engineered cerebral organoids model brain tumor formation. Nat Methods. 2018;15(8):631\u20139.","journal-title":"Nat Methods"},{"issue":"3","key":"2678_CR82","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1158\/0008-5472.CAN-24-0775","volume":"85","author":"FP Madorsky Rowdo","year":"2025","unstructured":"Madorsky Rowdo FP, Martini R, Ackermann SE, Tang CP, Tranquille M, Irizarry A, Us I, Alawa O, Moyer JE, Sigouros M, et al. Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition. Cancer Res. 2025;85(3):551\u201366.","journal-title":"Cancer Res"},{"issue":"5","key":"2678_CR83","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.medj.2023.04.003","volume":"4","author":"R Millen","year":"2023","unstructured":"Millen R, De Kort WWB, Koomen M, van Son GJF, Gobits R, Penning de Vries B, Begthel H, Zandvliet M, Doornaert P, Raaijmakers CPJ, et al. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification. Med. 2023;4(5):290\u2013310. e212.","journal-title":"Med"},{"issue":"1","key":"2678_CR84","doi-asserted-by":"publisher","first-page":"101978","DOI":"10.1016\/j.xpro.2022.101978","volume":"4","author":"DKH Chan","year":"2023","unstructured":"Chan DKH, Collins SD, Buczacki SJA. Generation and immunofluorescent validation of gene knockouts in adult human colonic organoids using multi-guide RNA CRISPR-Cas9. STAR Protoc. 2023;4(1):101978.","journal-title":"STAR Protoc"},{"issue":"13","key":"2678_CR85","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.7150\/ijbs.96469","volume":"20","author":"A Esposito","year":"2024","unstructured":"Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran DN, Isidoro C. Three-Dimensional In Vitro Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research. Int J Biol Sci. 2024;20(13):5293\u2013311.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"2678_CR86","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac H, Belleau P, Engle DD, Plenker D, Deschenes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, et al. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov. 2018;8(9):1112\u201329.","journal-title":"Cancer Discov"},{"issue":"1","key":"2678_CR87","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13046-023-02899-4","volume":"42","author":"SY Lee","year":"2023","unstructured":"Lee SY, Cho HJ, Choi J, Ku B, Moon SW, Moon MH, Kim KS, Hyun K, Kim TJ, Sung YE, et al. Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2023;42(1):309.","journal-title":"J Exp Clin Cancer Res"},{"key":"2678_CR88","unstructured":"Ooft SN, Weeber F, Dijkstra KK, McLean CM, Kaing S, van Werkhoven E, Schipper L, Hoes L, Vis DJ, van de Haar J et al. Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019;11(513):eaay2574."},{"issue":"6378","key":"2678_CR89","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernandez-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359(6378):920\u20136.","journal-title":"Science"},{"issue":"5","key":"2678_CR90","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000543983","volume":"109","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu R, Zhang Y, Zhou Z. Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing. Urol Int. 2025;109(5):478\u201386.","journal-title":"Urol Int"},{"issue":"3","key":"2678_CR91","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ygyno.2020.03.026","volume":"157","author":"H Chen","year":"2020","unstructured":"Chen H, Gotimer K, De Souza C, Tepper CG, Karnezis AN, Leiserowitz GS, Chien J, Smith LH. Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol. 2020;157(3):783\u201392.","journal-title":"Gynecol Oncol"},{"key":"2678_CR92","doi-asserted-by":"publisher","first-page":"114751","DOI":"10.1016\/j.biopha.2023.114751","volume":"163","author":"M Zu","year":"2023","unstructured":"Zu M, Hao X, Ning J, Zhou X, Gong Y, Lang Y, Xu W, Zhang J, Ding S. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing. Biomed Pharmacother. 2023;163:114751.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2678_CR93","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.21037\/jgo-2025-130","volume":"16","author":"X Yu","year":"2025","unstructured":"Yu X, Fang Y, Zhao Y, Xiao J, Chen S, Shi Z. A promising model for prediction of chemotherapeutic sensitivity in gastrointestinal cancers using patient-derived malignant ascites organoids. J Gastrointest Oncol. 2025;16(5):1944\u201361.","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"2678_CR94","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1002\/1878-0261.13144","volume":"16","author":"YW Cho","year":"2022","unstructured":"Cho YW, Min DW, Kim HP, An Y, Kim S, Youk J, Chun J, Im JP, Song SH, Ju YS, et al. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer. Mol Oncol. 2022;16(12):2396\u2013412.","journal-title":"Mol Oncol"},{"issue":"5","key":"2678_CR95","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/DCR.0000000000002511","volume":"66","author":"T Wang","year":"2023","unstructured":"Wang T, Tang Y, Pan W, Yan B, Hao Y, Zeng Y, Chen Z, Lan J, Zhao S, Deng C, et al. Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients With Stage IV Colorectal Cancer After Surgery. Dis Colon Rectum. 2023;66(5):733\u201343.","journal-title":"Dis Colon Rectum"},{"issue":"23","key":"2678_CR96","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-25-1564","volume":"31","author":"LP Smabers","year":"2025","unstructured":"Smabers LP, Wensink GE, Verissimo CS, Doorn M, Yang T, Voskuilen T, Huismans MA, Valkenburg-van Iersel LBJ, Cirkel GA, Gootjes EC, et al. Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer. Clin cancer research: official J Am Association Cancer Res. 2025;31(23):5015\u201326.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"key":"2678_CR97","doi-asserted-by":"crossref","unstructured":"Huang L, Bockorny B, Paul I, Akshinthala D, Frappart PO, Gandarilla O, Bose A, Sanchez-Gonzalez V, Rouse EE, Lehoux SD et al. PDX-derived organoids model in vivo drug response and secrete biomarkers. JCI Insight. 2020;5(21):e135544.","DOI":"10.1172\/jci.insight.135544"},{"issue":"5","key":"2678_CR98","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/path.5906","volume":"257","author":"A Hennig","year":"2022","unstructured":"Hennig A, Baenke F, Klimova A, Drukewitz S, Jahnke B, Bruckmann S, Secci R, Winter C, Schmache T, Seidlitz T, et al. Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment. J Pathol. 2022;257(5):607\u201319.","journal-title":"J Pathol"},{"key":"2678_CR99","first-page":"205","volume":"53","author":"C Zheng","year":"2025","unstructured":"Zheng C, Wang P, Zhang D, Fang Z, Feng Y, Chen J, Chen J, Fu Y, Yang B, Yu S, et al. A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation. Bioact Mater. 2025;53:205\u201317.","journal-title":"Bioact Mater"},{"issue":"1","key":"2678_CR100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/odi.15044","volume":"31","author":"XY Zhang","year":"2025","unstructured":"Zhang XY, Sui Y, Shan XF, Wang LM, Zhang L, Xie S, Cai ZG. Construction of oral squamous cell carcinoma organoids in vitro 3D-culture for drug screening. Oral Dis. 2025;31(1):99\u2013109.","journal-title":"Oral Dis"},{"issue":"1","key":"2678_CR101","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1002\/ctm2.678","volume":"12","author":"B Yuan","year":"2022","unstructured":"Yuan B, Zhao X, Wang X, Liu E, Liu C, Zong Y, Jiang Y, Hou M, Chen Y, Chen L, et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening. Clin Transl Med. 2022;12(1):e678.","journal-title":"Clin Transl Med"},{"issue":"3","key":"2678_CR102","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.3802\/jgo.2023.34.e35","volume":"34","author":"HS Seol","year":"2023","unstructured":"Seol HS, Oh JH, Choi E, Kim S, Kim H, Nam EJ. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine. J Gynecol Oncol. 2023;34(3):e35.","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"2678_CR103","doi-asserted-by":"publisher","first-page":"e970","DOI":"10.1002\/ctm2.970","volume":"12","author":"Z Li","year":"2022","unstructured":"Li Z, Xu H, Yu L, Wang J, Meng Q, Mei H, Cai Z, Chen W, Huang W. Patient-derived renal cell carcinoma organoids for personalized cancer therapy. Clin Transl Med. 2022;12(7):e970.","journal-title":"Clin Transl Med"},{"issue":"706","key":"2678_CR104","doi-asserted-by":"publisher","first-page":"eadg3358","DOI":"10.1126\/scitranslmed.adg3358","volume":"15","author":"S Ji","year":"2023","unstructured":"Ji S, Feng L, Fu Z, Wu G, Wu Y, Lin Y, Lu D, Song Y, Cui P, Yang Z, et al. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Sci Transl Med. 2023;15(706):eadg3358.","journal-title":"Sci Transl Med"},{"key":"2678_CR105","doi-asserted-by":"publisher","first-page":"107533","DOI":"10.1016\/j.lungcan.2024.107533","volume":"190","author":"JA Taverna","year":"2024","unstructured":"Taverna JA, Hung CN, Williams M, Williams R, Chen M, Kamali S, Sambandam V, Hsiang-Ling Chiu C, Osmulski PA, Gaczynska ME, et al. Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine. Lung Cancer. 2024;190:107533.","journal-title":"Lung Cancer"},{"issue":"1","key":"2678_CR106","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41698-024-00609-7","volume":"8","author":"SH Lee","year":"2024","unstructured":"Lee SH, Kim K, Lee E, Lee K, Ahn KH, Park H, Kim Y, Shin S, Jeon SY, Hwang Y, et al. Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion. NPJ Precis Oncol. 2024;8(1):111.","journal-title":"NPJ Precis Oncol"},{"key":"2678_CR107","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jcis.2024.07.010","volume":"675","author":"Z Gong","year":"2024","unstructured":"Gong Z, Mao Y, Liu Y, Hu X, Zhang Y, Zhu L, Guo S, Ding Z, Zhang L. Sono-promoted piezocatalysis and low-dose drug penetration for personalized therapy via tumor organoids. J Colloid Interface Sci. 2024;675:192\u2013206.","journal-title":"J Colloid Interface Sci"},{"issue":"10","key":"2678_CR108","doi-asserted-by":"publisher","first-page":"e30985","DOI":"10.1016\/j.heliyon.2024.e30985","volume":"10","author":"H Lin","year":"2024","unstructured":"Lin H, Fu H, Sun S, Yin H, Yuan J, Liao J. Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing. Heliyon. 2024;10(10):e30985.","journal-title":"Heliyon"},{"issue":"5","key":"2678_CR109","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s13402-022-00707-3","volume":"45","author":"L Xian","year":"2022","unstructured":"Xian L, Zhao P, Chen X, Wei Z, Ji H, Zhao J, Liu W, Li Z, Liu D, Han X, et al. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer. Cell Oncol (Dordr). 2022;45(5):1019\u201336.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"2678_CR110","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41420-024-01871-1","volume":"10","author":"S Roy","year":"2024","unstructured":"Roy S, Dukic T, Keepers Z, Bhandary B, Lamichhane N, Molitoris J, Ko YH, Banerjee A, Shukla HD. SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids. Cell Death Discov. 2024;10(1):106.","journal-title":"Cell Death Discov"},{"issue":"11","key":"2678_CR111","doi-asserted-by":"publisher","first-page":"e2003897","DOI":"10.1002\/advs.202003897","volume":"8","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Li ZX, Zhu YJ, Fu J, Zhao XF, Zhang YN, Wang S, Wu JM, Wang KT, Wu R, et al. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Adv Sci (Weinh). 2021;8(11):e2003897.","journal-title":"Adv Sci (Weinh)"},{"key":"2678_CR112","doi-asserted-by":"publisher","first-page":"101201","DOI":"10.1016\/j.drup.2025.101201","volume":"79","author":"K Li","year":"2025","unstructured":"Li K, Li W, Fu S, Wang C, Wang K, Yang H, Xian Y, Hao T, Zhang S, Gao T, et al. Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment. Drug Resist Updat. 2025;79:101201.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"2678_CR113","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1186\/s12885-025-14811-8","volume":"25","author":"P Nikeghbal","year":"2025","unstructured":"Nikeghbal P, Zamanian D, Burke D, Steinkamp MP. Organoid models established from primary tumors and patient-derived xenograft tumors reflect platinum sensitivity of ovarian cancer patients. BMC Cancer. 2025;25(1):1459.","journal-title":"BMC Cancer"},{"key":"2678_CR114","doi-asserted-by":"publisher","first-page":"217064","DOI":"10.1016\/j.canlet.2024.217064","volume":"597","author":"H Meng","year":"2024","unstructured":"Meng H, Miao H, Zhang Y, Chen T, Yuan L, Wan Y, Jiang Y, Zhang L, Cheng W. YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification. Cancer Lett. 2024;597:217064.","journal-title":"Cancer Lett"},{"issue":"1","key":"2678_CR115","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/s41467-023-38581-8","volume":"14","author":"TL Wong","year":"2023","unstructured":"Wong TL, Loh JJ, Lu S, Yan HHN, Siu HC, Xi R, Chan D, Kam MJF, Zhou L, Tong M, et al. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. Nat Commun. 2023;14(1):2861.","journal-title":"Nat Commun"},{"issue":"4","key":"2678_CR116","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024;5(4):572\u201389.","journal-title":"Nat Cancer"},{"issue":"6","key":"2678_CR117","first-page":"1155","volume":"45","author":"G Chen","year":"2022","unstructured":"Chen G, Gong T, Wang Z, Wang Z, Lin X, Chen S, Sun C, Zhao W, Kong Y, Ai H, et al. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cell Oncol (Dordr). 2022;45(6):1155\u201367.","journal-title":"Cell Oncol (Dordr)"},{"issue":"23","key":"2678_CR118","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1158\/1078-0432.CCR-21-1681","volume":"27","author":"EA Farshadi","year":"2021","unstructured":"Farshadi EA, Chang J, Sampadi B, Doukas M, Van \u2018t Land F, van der Sijde F, Vietsch EE, Pothof J, Koerkamp BG, van Eijck CHJ. Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma. Clin cancer research: official J Am Association Cancer Res. 2021;27(23):6602\u201312.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"1","key":"2678_CR119","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41420-025-02567-w","volume":"11","author":"K Nakano","year":"2025","unstructured":"Nakano K, Oki E, Yamazaki M, Suzuki M, Kawai S, Fujita T, Kato A, Zaitsu Y, Jogo T, Kato C, et al. Colorectal cancer cell line-derived organoid model with stem cell properties captures the regrowing state of residual cancer cells after neoadjuvant chemotherapy. Cell Death Discov. 2025;11(1):282.","journal-title":"Cell Death Discov"},{"issue":"12","key":"2678_CR120","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1158\/1535-7163.MCT-24-1096","volume":"24","author":"RA DeStefanis","year":"2025","unstructured":"DeStefanis RA, Schmitz AE, Steimle AK, Payne SN, Sha GC, Olson AM, Cornelio A, Lippert AEL, Kraus SG, Johnson KA, et al. BCL-2 Family Inhibition Enhances mTORC1\/2 Inhibition in PIK3CA-Mutant Colorectal Cancer. Mol Cancer Ther. 2025;24(12):1914\u201327.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2678_CR121","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-023-02671-8","volume":"42","author":"T Zhou","year":"2023","unstructured":"Zhou T, Xie Y, Hou X, Bai W, Li X, Liu Z, Man Q, Sun J, Fu D, Yan J, et al. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo\/YAP1\/c-Jun axis. J Exp Clin Cancer Res. 2023;42(1):111.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"2678_CR122","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/ten.tec.2021.0060","volume":"27","author":"AJ Dominijanni","year":"2021","unstructured":"Dominijanni AJ, Devarasetty M, Forsythe SD, Votanopoulos KI, Soker S. Cell Viability Assays in Three-Dimensional Hydrogels: A Comparative Study of Accuracy. Tissue Eng Part C Methods. 2021;27(7):401\u201310.","journal-title":"Tissue Eng Part C Methods"},{"issue":"3","key":"2678_CR123","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.slasd.2021.11.003","volume":"27","author":"A Stern","year":"2022","unstructured":"Stern A, Thompson B, Williams K, McClellan R, Gebhart S, Hartman J. The CellRaft AIR(\u00ae) system: A novel system enabling organoid imaging, identification, and isolation. SLAS Discov. 2022;27(3):201\u20138.","journal-title":"SLAS Discov"},{"key":"2678_CR124","doi-asserted-by":"crossref","unstructured":"Schnalzger TE, de Groot MH, Zhang C, Mosa MH, Michels BE, Roder J, Darvishi T, Wels WS, Farin HF. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. EMBO J. 2019;38(12):EMBJ2018100928.","DOI":"10.15252\/embj.2018100928"},{"key":"2678_CR125","doi-asserted-by":"crossref","unstructured":"Van Hemelryk A, Erkens-Schulze S, Lim L, de Ridder CMA, Stuurman DC, Jenster GW, van Royen ME, van Weerden WM. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids. Cells. 2023;12(10):1377.","DOI":"10.3390\/cells12101377"},{"issue":"1","key":"2678_CR126","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41587-022-01397-w","volume":"41","author":"JF Dekkers","year":"2023","unstructured":"Dekkers JF, Alieva M, Cleven A, Keramati F, Wezenaar AKL, van Vliet EJ, Puschhof J, Brazda P, Johanna I, Meringa AD, et al. Uncovering the mode of action of engineered T cells in patient cancer organoids. Nat Biotechnol. 2023;41(1):60\u20139.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2678_CR127","doi-asserted-by":"publisher","first-page":"104250","DOI":"10.1016\/j.xpro.2025.104250","volume":"6","author":"JS Choi","year":"2025","unstructured":"Choi JS, Lee MS, Song MJ, Jeong K. Protocol for high-content drug screening using tumor organoids on a 384-pillar plate platform. STAR Protoc. 2025;6(4):104250.","journal-title":"STAR Protoc"},{"issue":"1","key":"2678_CR128","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41698-023-00480-y","volume":"7","author":"M Le Compte","year":"2023","unstructured":"Le Compte M, De La Hoz EC, Peeters S, Fortes FR, Hermans C, Domen A, Smits E, Lardon F, Vandamme T, Lin A, et al. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer. NPJ Precis Oncol. 2023;7(1):128.","journal-title":"NPJ Precis Oncol"},{"issue":"11","key":"2678_CR129","doi-asserted-by":"publisher","first-page":"e1010584","DOI":"10.1371\/journal.pcbi.1010584","volume":"18","author":"JM Matthews","year":"2022","unstructured":"Matthews JM, Schuster B, Kashaf SS, Liu P, Ben-Yishay R, Ishay-Ronen D, Izumchenko E, Shen L, Weber CR, Bielski M, et al. OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics. PLoS Comput Biol. 2022;18(11):e1010584.","journal-title":"PLoS Comput Biol"},{"key":"2678_CR130","doi-asserted-by":"publisher","first-page":"771173","DOI":"10.3389\/fonc.2021.771173","volume":"11","author":"ER Spiller","year":"2021","unstructured":"Spiller ER, Ung N, Kim S, Patsch K, Lau R, Strelez C, Doshi C, Choung S, Choi B, Juarez Rosales EF, et al. Imaging-Based Machine Learning Analysis of Patient-Derived Tumor Organoid Drug Response. Front Oncol. 2021;11:771173.","journal-title":"Front Oncol"},{"key":"2678_CR131","doi-asserted-by":"crossref","unstructured":"Saad SH, Kashanchi A, Zadeh MA, Williams A, Batrakova EV. Exosome-Mediated Crosstalk Between Cancer Cells and Tumor Microenvironment. Cells. 2025;14(22):1750.","DOI":"10.3390\/cells14221750"},{"issue":"6","key":"2678_CR132","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. Cell. 2018;174(6):1586\u201398. e1512.","journal-title":"Cell"},{"issue":"1","key":"2678_CR133","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","volume":"41","author":"S Schuth","year":"2022","unstructured":"Schuth S, Le Blanc S, Krieger TG, Jabs J, Schenk M, Giese NA, Buchler MW, Eils R, Conrad C, Strobel O. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J Exp Clin Cancer Res. 2022;41(1):312.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"2678_CR134","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"Farin HF, Mosa MH, Ndreshkjana B, Grebbin BM, Ritter B, Menche C, Kennel KB, Ziegler PK, Szabo L, Bollrath J, et al. Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses. Cancer Discov. 2023;13(10):2192\u2013211.","journal-title":"Cancer Discov"},{"key":"2678_CR135","unstructured":"Chakrabarti J, Koh V, So JBY, Yong WP, Zavros Y. A Preclinical Human-Derived Autologous Gastric Cancer Organoid\/Immune Cell Co-Culture Model to Predict the Efficacy of Targeted Therapies. J Vis Exp. 2021;(173):e61443."},{"key":"2678_CR136","doi-asserted-by":"publisher","first-page":"1133796","DOI":"10.3389\/fimmu.2023.1133796","volume":"14","author":"NA Beelen","year":"2023","unstructured":"Beelen NA, Aberle MR, Bruno V, Olde Damink SWM, Bos GMJ, Rensen SS, Wieten L. Antibody-dependent cellular cytotoxicity-inducing antibodies enhance the natural killer cell anti-cancer response against patient-derived pancreatic cancer organoids. Front Immunol. 2023;14:1133796.","journal-title":"Front Immunol"},{"issue":"6","key":"2678_CR137","doi-asserted-by":"publisher","first-page":"100792","DOI":"10.1016\/j.crmeth.2024.100792","volume":"4","author":"A Raffo-Romero","year":"2024","unstructured":"Raffo-Romero A, Ziane-Chaouche L, Salome-Desnoulez S, Hajjaji N, Fournier I, Salzet M, Duhamel M. A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses. Cell Rep Methods. 2024;4(6):100792.","journal-title":"Cell Rep Methods"},{"issue":"17","key":"2678_CR138","doi-asserted-by":"publisher","first-page":"e36377","DOI":"10.1016\/j.heliyon.2024.e36377","volume":"10","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li Q, Ye Q, Jin Y, Yu Y, Zhang X, Xi L, Wang Y, Wu D, Pan Y, et al. Construction and drug screening of Co-culture system using extrahepatic cholangiocarcinoma organoids and tumor-associated macrophages. Heliyon. 2024;10(17):e36377.","journal-title":"Heliyon"},{"issue":"2","key":"2678_CR139","doi-asserted-by":"publisher","first-page":"111827","DOI":"10.1016\/j.isci.2025.111827","volume":"28","author":"SA Revilla","year":"2025","unstructured":"Revilla SA, Frederiks CL, Prekovic S, Mocholi E, Kranenburg O, Coffer PJ. Tumor-derived colorectal cancer organoids induce a unique Treg cell population by directing CD4(+) T cell differentiation. Iscience. 2025;28(2):111827.","journal-title":"Iscience"},{"key":"2678_CR140","doi-asserted-by":"publisher","first-page":"1105244","DOI":"10.3389\/fimmu.2023.1105244","volume":"14","author":"B Subtil","year":"2023","unstructured":"Subtil B, Iyer KK, Poel D, Bakkerus L, Gorris MAJ, Escalona JC, van den Dries K, Cambi A, Verheul HMW, de Vries IJM, et al. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids. Front Immunol. 2023;14:1105244.","journal-title":"Front Immunol"},{"issue":"6","key":"2678_CR141","doi-asserted-by":"publisher","first-page":"e2350891","DOI":"10.1002\/eji.202350891","volume":"54","author":"B Subtil","year":"2024","unstructured":"Subtil B, van der Hoorn IAE, Cuenca-Escalona J, Becker AMD, Alvarez-Begue M, Iyer KK, Janssen J, van Oorschot T, Poel D, Gorris MAJ, et al. cDC2 plasticity and acquisition of a DC3-like phenotype mediated by IL-6 and PGE2 in a patient-derived colorectal cancer organoids model. Eur J Immunol. 2024;54(6):e2350891.","journal-title":"Eur J Immunol"},{"issue":"6","key":"2678_CR142","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.3390\/cimb46060346","volume":"46","author":"KB Ryu","year":"2024","unstructured":"Ryu KB, Seo JA, Lee K, Choi J, Yoo G, Ha JH, Ahn MR. Drug-Resistance Biomarkers in Patient-Derived Colorectal Cancer Organoid and Fibroblast Co-Culture System. Curr Issues Mol Biol. 2024;46(6):5794\u2013811.","journal-title":"Curr Issues Mol Biol"},{"key":"2678_CR143","doi-asserted-by":"crossref","unstructured":"Kabiljo J, Theophil A, Homola J, Renner AF, Sturzenbecher N, Ammon D, Zirnbauer R, Stang S, Tran L, Laengle J et al. Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures. J Immunother Cancer. 2024;12(11):e009494.","DOI":"10.1136\/jitc-2024-009494"},{"issue":"4","key":"2678_CR144","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41416-022-01839-x","volume":"127","author":"G Zhou","year":"2022","unstructured":"Zhou G, Lieshout R, van Tienderen GS, de Ruiter V, van Royen ME, Boor PPC, Magre L, Desai J, Koten K, Kan YY, et al. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. Br J Cancer. 2022;127(4):649\u201360.","journal-title":"Br J Cancer"},{"issue":"11","key":"2678_CR145","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41551-021-00805-x","volume":"5","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, et al. An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nat Biomed Eng. 2021;5(11):1320\u201335.","journal-title":"Nat Biomed Eng"},{"issue":"8","key":"2678_CR146","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.stem.2025.05.011","volume":"32","author":"K Li","year":"2025","unstructured":"Li K, Liu C, Sui X, Li C, Zhang T, Zhao T, Zhang D, Wu H, Liu Y, Wang S, et al. An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer. Cell Stem Cell. 2025;32(8):1218\u201334. e1217.","journal-title":"Cell Stem Cell"},{"issue":"43","key":"2678_CR147","doi-asserted-by":"publisher","first-page":"eadg6686","DOI":"10.1126\/sciadv.adg6686","volume":"9","author":"L Sun","year":"2023","unstructured":"Sun L, Kang X, Ju H, Wang C, Yang G, Wang R, Sun S. A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options. Sci Adv. 2023;9(43):eadg6686.","journal-title":"Sci Adv"},{"issue":"1","key":"2678_CR148","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13046-023-02756-4","volume":"42","author":"S Jiang","year":"2023","unstructured":"Jiang S, Deng T, Cheng H, Liu W, Shi D, Yuan J, He Z, Wang W, Chen B, Ma L, et al. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance. J Exp Clin Cancer Res. 2023;42(1):199.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"2678_CR149","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s00262-024-03749-8","volume":"73","author":"Z Li","year":"2024","unstructured":"Li Z, Ma L, Gao Z, Wang X, Che X, Zhang P, Li Y, Zhang Q, Liu T, Sun Y, et al. Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures. Cancer Immunol immunotherapy: CII. 2024;73(9):164.","journal-title":"Cancer Immunol immunotherapy: CII"},{"key":"2678_CR150","doi-asserted-by":"publisher","first-page":"104614","DOI":"10.1016\/j.ebiom.2023.104614","volume":"92","author":"L Ou","year":"2023","unstructured":"Ou L, Liu S, Wang H, Guo Y, Guan L, Shen L, Luo R, Elder DE, Huang AC, Karakousis G, et al. Patient-derived melanoma organoid models facilitate the assessment of immunotherapies. EBioMedicine. 2023;92:104614.","journal-title":"EBioMedicine"},{"key":"2678_CR151","doi-asserted-by":"crossref","unstructured":"Feng Z, Li Y, Wu J, Yin J, Wang R, Liang S. Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs). J Vis Exp. 2025;(220):e68346.","DOI":"10.3791\/68346"},{"issue":"1","key":"2678_CR152","doi-asserted-by":"publisher","first-page":"99","DOI":"10.15283\/ijsc24021","volume":"18","author":"B Oh","year":"2025","unstructured":"Oh B, Kim J, Kim N, Jeong Y. Lung Cancer Organoid System to Evaluate the Cytotoxicity of Natural Killer Cells. Int J Stem Cells. 2025;18(1):99\u2013106.","journal-title":"Int J Stem Cells"},{"issue":"1","key":"2678_CR153","doi-asserted-by":"publisher","first-page":"1845424","DOI":"10.1080\/2162402X.2020.1845424","volume":"9","author":"F Marcon","year":"2020","unstructured":"Marcon F, Zuo J, Pearce H, Nicol S, Margielewska-Davies S, Farhat M, Mahon B, Middleton G, Brown R, Roberts KJ, et al. NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype. Oncoimmunology. 2020;9(1):1845424.","journal-title":"Oncoimmunology"},{"issue":"8","key":"2678_CR154","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.7150\/thno.96027","volume":"14","author":"D Xiang","year":"2024","unstructured":"Xiang D, He A, Zhou R, Wang Y, Xiao X, Gong T, Kang W, Lin X, Wang X, Consortium PD-bD, et al. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development. Theranostics. 2024;14(8):3300\u201316.","journal-title":"Theranostics"},{"issue":"1","key":"2678_CR155","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12943-024-02055-2","volume":"23","author":"M Yu","year":"2024","unstructured":"Yu M, Ni M, Xu F, Liu C, Chen L, Li J, Xia S, Diao Y, Chen J, Zhu J, et al. NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer. Mol Cancer. 2024;23(1):139.","journal-title":"Mol Cancer"},{"issue":"1","key":"2678_CR156","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-025-07582-4","volume":"16","author":"H Shen","year":"2025","unstructured":"Shen H, Jin J, Yu N, Liu T, Nie Y, Wan Z, Chen Y, Cao K, Xu Y, Huang Y, et al. PRKCSH enhances colorectal cancer radioresistance via IRE1alpha\/XBP1s-mediated DNA repair. Cell Death Dis. 2025;16(1):258.","journal-title":"Cell Death Dis"},{"issue":"37","key":"2678_CR157","doi-asserted-by":"publisher","first-page":"e07080","DOI":"10.1002\/advs.202507080","volume":"12","author":"Q Chen","year":"2025","unstructured":"Chen Q, Jin Y, Liao L, Shen R, Ge X, Jiang Q, Huang Y, Sun Q, Liu D, Liu L, et al. Patients-Derived Organoids Sequencing-based FOXP4 Facilitates Radioresistance by Transcriptionally Modifying GPX4 to Regulate ferroptosis in Colorectal Cancer. Adv Sci (Weinh). 2025;12(37):e07080.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2678_CR158","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s12967-025-06648-3","volume":"23","author":"J Wang","year":"2025","unstructured":"Wang J, Li L, Qin Y, Zhang W. TTI1 contributes to radioresistance by activating ATM pathway in rectal cancer. J Transl Med. 2025;23(1):652.","journal-title":"J Transl Med"},{"issue":"1","key":"2678_CR159","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13046-025-03349-z","volume":"44","author":"P Mu","year":"2025","unstructured":"Mu P, Mo S, He X, Zhang H, Lv T, Xu R, He L, Xia F, Zhou S, Chen Y, et al. Unveiling radiobiological traits and therapeutic responses of BRAF(V600E)-mutant colorectal cancer via patient-derived organoids. J Exp Clin Cancer Res. 2025;44(1):92.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2678_CR160","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13046-025-03345-3","volume":"44","author":"C Issing","year":"2025","unstructured":"Issing C, Menche C, Richter MR, Mosa MH, von der Grun J, Fleischmann M, Thoenissen P, Winkelmann R, Darvishi T, Loth AG, et al. Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53\/HPV status. J Exp Clin Cancer Res. 2025;44(1):85.","journal-title":"J Exp Clin Cancer Res"},{"key":"2678_CR161","doi-asserted-by":"publisher","first-page":"622244","DOI":"10.3389\/fonc.2021.622244","volume":"11","author":"SS Lucky","year":"2021","unstructured":"Lucky SS, Law M, Lui MH, Mong J, Shi J, Yu S, Yoon DK, Djeng SK, Wang J, Lim CM, et al. Patient-Derived Nasopharyngeal Cancer Organoids for Disease Modeling and Radiation Dose Optimization. Front Oncol. 2021;11:622244.","journal-title":"Front Oncol"},{"issue":"6","key":"2678_CR162","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.3892\/ijo.2020.5132","volume":"57","author":"M Park","year":"2020","unstructured":"Park M, Kwon J, Shin HJ, Moon SM, Kim SB, Shin US, Han YH, Kim Y. Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient\u2013derived organoids. Int J Oncol. 2020;57(6):1307\u201318.","journal-title":"Int J Oncol"},{"key":"2678_CR163","doi-asserted-by":"crossref","unstructured":"Clifford RE, Govindarajah N, Bowden D, Sutton P, Glenn M, Darvish-Damavandi M, Buczacki S, McDermott U, Szulc Z, Ogretmen B et al. Targeting Acid Ceramidase to Improve the Radiosensitivity of Rectal Cancer. Cells. 2020;9(12):2693.","DOI":"10.3390\/cells9122693"},{"key":"2678_CR164","doi-asserted-by":"publisher","first-page":"920444","DOI":"10.3389\/fonc.2022.920444","volume":"12","author":"K Wanigasooriya","year":"2022","unstructured":"Wanigasooriya K, Barros-Silva JD, Tee L, El-Asrag ME, Stodolna A, Pickles OJ, Stockton J, Bryer C, Hoare R, Whalley CM, et al. Patient Derived Organoids Confirm That PI3K\/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer. Front Oncol. 2022;12:920444.","journal-title":"Front Oncol"},{"key":"2678_CR165","doi-asserted-by":"crossref","unstructured":"Putker M, Millen R, Overmeer R, Driehuis E, Zandvliet M, Clevers H, Boj SF, Li QX. Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids. J Vis Exp. 2021;(170):e62495.","DOI":"10.3791\/62495"},{"issue":"1","key":"2678_CR166","doi-asserted-by":"publisher","first-page":"24221","DOI":"10.1038\/s41598-025-88082-5","volume":"15","author":"W Li","year":"2025","unstructured":"Li W, Nishino M, Reed E, Akshinthala D, Pasha HA, Anderson ES, Huang L, Hebestreit H, Monti S, Gomez ED, et al. Head and neck tumor organoid grown under simplified media conditions model tumor biology and chemoradiation responses. Sci Rep. 2025;15(1):24221.","journal-title":"Sci Rep"},{"issue":"3","key":"2678_CR167","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.stem.2024.01.012","volume":"31","author":"JM Kastenschmidt","year":"2024","unstructured":"Kastenschmidt JM, Schroers-Martin JG, Sworder BJ, Sureshchandra S, Khodadoust MS, Liu CL, Olsen M, Kurtz DM, Diehn M, Wagar LE, et al. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment. Cell Stem Cell. 2024;31(3):410\u201320. e414.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2678_CR168","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.ccell.2023.11.007","volume":"41","author":"TL Dayton","year":"2023","unstructured":"Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, Lap L, Dost AFM, Beumer J, Levy S, et al. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 2023;41(12):2083\u201399. e2089.","journal-title":"Cancer Cell"},{"issue":"8","key":"2678_CR169","first-page":"780","volume":"26","author":"YL Zeng","year":"2023","unstructured":"Zeng YL, Wang SD, Li YR, Xue WS, Wang T, Tang YT, Zheng H, Chen ZX, Lan JQ, Yan J. [Analysis of factors influencing the success rate of organoid culture in 1231 cases of colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi. 2023;26(8):780\u20136.","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"4","key":"2678_CR170","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jcf.2024.04.016","volume":"23","author":"MC Bierlaagh","year":"2024","unstructured":"Bierlaagh MC, van Mourik P, Vonk AM, Pott J, Muilwijk D, Berkers G, Aalbers BL, Vleggaar FP, Michel S, Boj SF, et al. Centralized intestinal organoid generation is a feasible and safe approach for personalized medicine as demonstrated in the HIT-CF Europe Organoid Study. J Cyst Fibros. 2024;23(4):703\u20136.","journal-title":"J Cyst Fibros"},{"key":"2678_CR171","doi-asserted-by":"publisher","first-page":"123546","DOI":"10.1016\/j.biomaterials.2025.123546","volume":"324","author":"H Ma","year":"2026","unstructured":"Ma H, Li X, Li J, Bu J, Li X, Zhang J, Yu S, Nie G, Wang H, Feng H. Generation of patient-derived sarcoma organoids for personalized drug screening and precision cancer immunotherapy. Biomaterials. 2026;324:123546.","journal-title":"Biomaterials"},{"key":"2678_CR172","doi-asserted-by":"publisher","first-page":"106186","DOI":"10.1016\/j.oraloncology.2022.106186","volume":"135","author":"G Lassche","year":"2022","unstructured":"Lassche G, van Boxtel W, Aalders TW, van Hooij O, van Engen-van Grunsven ACH, Verhaegh GW, van Herpen CML, Schalken JA. Development and characterization of patient-derived salivary gland cancer organoid cultures. Oral Oncol. 2022;135:106186.","journal-title":"Oral Oncol"},{"issue":"9","key":"2678_CR173","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","volume":"39","author":"V Veninga","year":"2021","unstructured":"Veninga V, Voest EE. Tumor organoids: Opportunities and challenges to guide precision medicine. Cancer Cell. 2021;39(9):1190\u2013201.","journal-title":"Cancer Cell"},{"issue":"1","key":"2678_CR174","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13073-023-01259-3","volume":"15","author":"A Sathe","year":"2023","unstructured":"Sathe A, Ayala C, Bai X, Grimes SM, Lee B, Kin C, Shelton A, Poultsides G, Ji HP. GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers. Genome Med. 2023;15(1):100.","journal-title":"Genome Med"},{"issue":"12","key":"2678_CR175","doi-asserted-by":"publisher","first-page":"e1670019","DOI":"10.1080\/2162402X.2019.1670019","volume":"8","author":"R Sivakumar","year":"2019","unstructured":"Sivakumar R, Chan M, Shin JS, Nishida-Aoki N, Kenerson HL, Elemento O, Beltran H, Yeung R, Gujral TS. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery. Oncoimmunology. 2019;8(12):e1670019.","journal-title":"Oncoimmunology"},{"issue":"1","key":"2678_CR176","doi-asserted-by":"publisher","first-page":"15334","DOI":"10.1038\/s41598-022-19555-0","volume":"12","author":"A Runge","year":"2022","unstructured":"Runge A, Mayr M, Schwaiger T, Sprung S, Chetta P, Gottfried T, Dudas J, Greier MC, Glatz MC, Haybaeck J, et al. Patient-derived head and neck tumor slice cultures: a versatile tool to study oncolytic virus action. Sci Rep. 2022;12(1):15334.","journal-title":"Sci Rep"},{"key":"2678_CR177","doi-asserted-by":"publisher","first-page":"893592","DOI":"10.3389\/fonc.2022.893592","volume":"12","author":"T Wakamatsu","year":"2022","unstructured":"Wakamatsu T, Ogawa H, Yoshida K, Matsuoka Y, Shizuma K, Imura Y, Tamiya H, Nakai S, Yagi T, Nagata S, et al. Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures. Front Oncol. 2022;12:893592.","journal-title":"Front Oncol"},{"key":"2678_CR178","doi-asserted-by":"publisher","first-page":"100486","DOI":"10.1016\/j.jbo.2023.100486","volume":"41","author":"R Suzuki","year":"2023","unstructured":"Suzuki R, Wakamatsu T, Yoshida K, Matsuoka Y, Takami H, Nakai S, Tamiya H, Kakunaga S, Yagi T, Yoshida KI, et al. Genetic characterization of a novel organoid from human malignant giant-cell tumor. J Bone Oncol. 2023;41:100486.","journal-title":"J Bone Oncol"},{"issue":"8103","key":"2678_CR179","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/d41586-026-00563-3","volume":"650","author":"D Kwon","year":"2026","unstructured":"Kwon D. The age of animal experiments is waning. Where will science go next? Nature. 2026;650(8103):812\u20134.","journal-title":"Nature"},{"issue":"9","key":"2678_CR180","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41573-025-01182-9","volume":"24","author":"M Beilmann","year":"2025","unstructured":"Beilmann M, Adkins K, Boonen HCM, Hewitt P, Hu W, Mader R, Moore S, Rana P, Steger-Hartmann T, Villenave R, et al. Application of new approach methodologies for nonclinical safety assessment of drug candidates. Nat Rev Drug Discov. 2025;24(9):705\u201325.","journal-title":"Nat Rev Drug Discov"},{"key":"2678_CR181","doi-asserted-by":"crossref","unstructured":"Zushin PH, Mukherjee S, Wu JC. FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches. J Clin Invest. 2023;133(21):1\u20134.","DOI":"10.1172\/JCI175824"},{"issue":"4","key":"2678_CR182","doi-asserted-by":"publisher","first-page":"100667","DOI":"10.1016\/j.medj.2025.100667","volume":"6","author":"L Zhou","year":"2025","unstructured":"Zhou L, Huang J, Li C, Gu Q, Li G, Li ZA, Xu J, Zhou J, Tuan RS. Organoids and organs-on-chips: Recent advances, applications in drug development, and regulatory challenges. Med. 2025;6(4):100667.","journal-title":"Med"},{"issue":"21","key":"2678_CR183","doi-asserted-by":"publisher","first-page":"e2302502","DOI":"10.1002\/adhm.202302502","volume":"13","author":"SY Kang","year":"2024","unstructured":"Kang SY, Kimura M, Shrestha S, Lewis P, Lee S, Cai Y, Joshi P, Acharya P, Liu J, Yang Y, et al. A Pillar and Perfusion Plate Platform for Robust Human Organoid Culture and Analysis. Adv Healthc Mater. 2024;13(21):e2302502.","journal-title":"Adv Healthc Mater"},{"issue":"4","key":"2678_CR184","doi-asserted-by":"publisher","first-page":"733","DOI":"10.18063\/ijb.733","volume":"9","author":"T Miao","year":"2023","unstructured":"Miao T, Chen K, Wei X, Huang B, Qian Y, Wang L, Xu M. High-throughput fabrication of cell spheroids with 3D acoustic assembly devices. Int J Bioprint. 2023;9(4):733.","journal-title":"Int J Bioprint"},{"issue":"2","key":"2678_CR185","doi-asserted-by":"publisher","first-page":"102","DOI":"10.15283\/ijsc24047","volume":"17","author":"SJ Ahn","year":"2024","unstructured":"Ahn SJ, Lee S, Kwon D, Oh S, Park C, Jeon S, Lee JH, Kim TS, Oh IU. Essential Guidelines for Manufacturing and Application of Organoids. Int J Stem Cells. 2024;17(2):102\u201312.","journal-title":"Int J Stem Cells"},{"issue":"7802","key":"2678_CR186","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","volume":"580","author":"C Pleguezuelos-Manzano","year":"2020","unstructured":"Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, et al. Mutational signature in colorectal cancer caused by genotoxic pks(+) E. coli. Nature. 2020;580(7802):269\u201373.","journal-title":"Nature"},{"issue":"1","key":"2678_CR187","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.stem.2022.12.013","volume":"30","author":"C Trentesaux","year":"2023","unstructured":"Trentesaux C, Yamada T, Klein OD, Lim WA. Harnessing synthetic biology to engineer organoids and tissues. Cell Stem Cell. 2023;30(1):10\u20139.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"2678_CR188","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.stem.2024.05.007","volume":"31","author":"O Mitrofanova","year":"2024","unstructured":"Mitrofanova O, Nikolaev M, Xu Q, Broguiere N, Cubela I, Camp JG, Bscheider M, Lutolf MP. Bioengineered human colon organoids with in vivo-like cellular complexity and function. Cell Stem Cell. 2024;31(8):1175\u2013e11861177.","journal-title":"Cell Stem Cell"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02678-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02678-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02678-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:12:54Z","timestamp":1783066374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02678-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":188,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02678-7","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}